Personal Details

Dr. Marc Brehme, MSc MBA

Senior Lecturer

marc.brehme@hcw.ac.at
+43 1 606 68 77-3510

Room: F.3.17
Favoritenstraße 222
1100 Wien

Focus

  • entrepreneurship & innovation in biotechnology & biopharma

  • strategy & management in life science start-up ventures

Study programs

Bachelor

Molecular Biotechnology

full-time

Master

Molecular Biotechnology

full-time

Departments
Applied Life Sciences

Lectures

Biotechnologie & Wir ILV

Biotechnologie & Wir ILV | WS2026/27

Content

- Die Bedeutung der Biotechnologie verstehen

 

- Onboarding

 

- Motivation und Zielsetzung

 

- Aufbau eines starken Fundaments in Schlüsselkompetenzen

 

- Karriereerkundung und Networking

 

- Ethische Überlegungen und aufkommende Trends

 

- Teil einer Community of Practice werden

Teaching method

Vortrag, Einzel- und Gruppenarbeit, Praktische Umsetzungsaufgaben, Selbsteinschätzung durch Übungen zur Selbst-Reflexion und individuellen Anwendung, Praxisübungen mit Feedback und Analyse

Examination

Immanente Leistungsüberprüfung

 

Leistungsüberprüfung (z.B. Präsentation, Diskussion, schriftliche Arbeit, Reflexion)

Teaching language

Deutsch-Englisch

Clinical Drug Development ILV

Clinical Drug Development ILV | WS2026/27

Content

- Classes of Pharmaceuticals (biopharmaceuticals and small-molecule drugs)

 

- Case studies: Clinical development of selected drugs

 

- Clinical drug development process

 

- Selected aspects of drug discovery and preclinical development

 

- Overview clinical study designs, outcomes and inclusion/exclusion criteria

 

- Randomized Controlled Trials (RCTs): Randomization, Blinding and Placebos

 

- Epidemiological study designs

 

- Conduct of clinical trials, data analysis and interpretation

 

- Ethical aspects, the origins and principles of Good Clinical Practice (GCP)

 

- Regulatory bodies, international regulations (EMEA, FDA, ICH)

 

- Phase IV/Post-marketing surveillance, life cycle management

 

- Interfaces: Regulatory Affairs and Pharmacovigilance, Marketing and Product Life Cycle Management

 

- Special chapters: Advanced Therapy Medicinal Products (ATMPs), repurposing, special populations

Teaching method

- Lecture with structured exercises

 

- Dialogue and discussion

 

- Group work

 

- Blended learning

 

- Guest lectures

Examination

Endprüfung

 

Exercises during class, exam

Teaching language

Englisch

Innovation in Biotechnology & Start-ups ILV

Innovation in Biotechnology & Start-ups ILV | WS2026/27

Content

- Knowledge Management: Definitions, R&D focus, human and data perspectives, tools, and practices.

 

- Innovation Management: From invention to innovation, strategic processes, and implementation.

 

- Business Plan Development:

- Vision, market analysis, financials, legal aspects, implementation planning.

- Four phases: idea, feedback, testing, launch.

 

- Key Tools: Porter's 5 Forces, SWOT, life-cycle analysis, Canvas Model, risk analysis.

Teaching method

- Lecture

 

- Dialogue and discussion

 

- Group work

 

- Supervised distance learning

 

- Self-study

 

- Project work

Examination

Endprüfung

 

Presentation of the group work, documentation of the group work either in Word or Powerpoint

Teaching language

Englisch